Health Care & Life Sciences » Healthcare Provision | Bioanalytical Systems Inc.

Bioanalytical Systems Inc. | Cash Flow

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
773.00
1,070.00
1,099.00
3,230.00
884.00
194
Depreciation, Depletion & Amortization
1,723.00
1,597.00
1,409.00
1,556.00
1,680.00
1,856
Other Funds
-
-
32.00
-
-
149
Funds from Operations
2,107.00
1,849.00
2,598.00
749.00
2,578.00
1,811
Changes in Working Capital
588.00
165.00
494.00
1,809.00
1,342.00
1,676
Net Operating Cash Flow
1,519.00
1,684.00
2,104.00
1,060.00
1,236.00
3,487
Capital Expenditures
8.00
490.00
1,467.00
1,256.00
347.00
Sale of Fixed Assets & Businesses
20.00
-
33.00
-
8.00
Net Investing Cash Flow
12.00
490.00
1,434.00
1,256.00
339.00
Issuance/Reduction of Debt, Net
947.00
1,699.00
1,181.00
141.00
920.00
Net Financing Cash Flow
947.00
1,513.00
1,213.00
144.00
849.00
Net Change in Cash
583.00
323.00
543.00
52.00
48.00
Free Cash Flow
1,511.00
1,194.00
637.00
196.00
889.00
Change in Capital Stock
-
186.00
-
3.00
71.00
Exchange Rate Effect
1.00
4.00
-
-
-

About Bioanalytical Systems

View Profile
Address
2701 Kent Avenue
West Lafayette Indiana 47906
United States
Employees -
Website http://www.basinc.com
Updated 07/08/2019
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company operates through through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.